Kidney cancer news
Quality of life and psychological distress in patients with small renal masses
Small renal masses are areas of abnormal tissue growth in [...]
Adjuvant nivolumab plus ipilimumab for kidney cancer
Adjuvant therapy is medication that is given after surgery to [...]
A moment to celebrate a potentially revolutionary cancer blood test trial
NHS England started a large-scale trial of a new blood [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
Attitudes towards pharmaceutical companies in the UK
A recent survey from the Association of the British Pharmaceutical [...]
Most used Tags
renal cell carcinoma immunotherapy checkpoint inhibitors combination therapy Cancer TKIs overall survival nivolumab Opdivo sunitinib Sutent progression-free survival cabozantinib NHS England biomarkers Cabometyx COVID-19 ipilimumab cancer survival VEGF inhibitors axitinib coronavirus Inlyta pembrolizumab non-clear cell kidney cancer Yervoy risk factors Keytruda biological markers metastases everolimus targeted therapy papillary RCC adjuvant therapy Afinitor ASCO cancer outcomes first-line treatment NICE partial nephrectomyArchives
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
